Denis G. Bosc

865 total citations
16 papers, 745 citations indexed

About

Denis G. Bosc is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Denis G. Bosc has authored 16 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Denis G. Bosc's work include Protein Kinase Regulation and GTPase Signaling (11 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Denis G. Bosc is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (11 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Denis G. Bosc collaborates with scholars based in Canada, United States and Germany. Denis G. Bosc's co-authors include David W. Litchfield, Ralf Janknecht, Basem S. Goueli, Bernhard Lüscher, Ronald B. Saulnier, Cunjie Zhang, Elissavet Kardami, Bradley W. Doble, Yijing Chen and R. Daniel Gietz and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Circulation Research.

In The Last Decade

Denis G. Bosc

16 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis G. Bosc Canada 15 611 169 105 59 57 16 745
Soula Ganiatsas United States 9 614 1.0× 248 1.5× 122 1.2× 156 2.6× 22 0.4× 10 829
Arindam Chaudhury United States 6 659 1.1× 197 1.2× 104 1.0× 67 1.1× 35 0.6× 6 847
Toshiyasu Shimomura Japan 13 556 0.9× 196 1.2× 194 1.8× 23 0.4× 37 0.6× 43 889
Sabita Sankar United States 10 534 0.9× 152 0.9× 43 0.4× 83 1.4× 48 0.8× 15 668
Cercina Onesto France 8 461 0.8× 124 0.7× 136 1.3× 51 0.9× 31 0.5× 10 624
Leon Parker United States 12 574 0.9× 130 0.8× 162 1.5× 53 0.9× 35 0.6× 13 720
María José Sandí France 13 462 0.8× 183 1.1× 166 1.6× 118 2.0× 74 1.3× 21 738
Alexander Kukalev Sweden 12 914 1.5× 304 1.8× 163 1.6× 60 1.0× 75 1.3× 21 1.1k
Marsha Crochiere United States 12 471 0.8× 176 1.0× 38 0.4× 35 0.6× 49 0.9× 35 618
Huiping Pei United States 10 606 1.0× 263 1.6× 49 0.5× 134 2.3× 57 1.0× 10 774

Countries citing papers authored by Denis G. Bosc

Since Specialization
Citations

This map shows the geographic impact of Denis G. Bosc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis G. Bosc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis G. Bosc more than expected).

Fields of papers citing papers by Denis G. Bosc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis G. Bosc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis G. Bosc. The network helps show where Denis G. Bosc may publish in the future.

Co-authorship network of co-authors of Denis G. Bosc

This figure shows the co-authorship network connecting the top 25 collaborators of Denis G. Bosc. A scholar is included among the top collaborators of Denis G. Bosc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis G. Bosc. Denis G. Bosc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Brown, Jennifer G., Michèle Rasamoelisolo, Maureen Spearman, et al.. (2009). Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration. Cancer Biotherapy and Radiopharmaceuticals. 24(4). 477–487. 14 indexed citations
2.
Brown, Jennifer G., et al.. (2008). Pre-clinical safety assessment of VB4-845, an EpCAM binding immunoconjugate. Cancer Research. 68. 2136–2136. 1 indexed citations
3.
Shin, Sook, Denis G. Bosc, James N. Ingle, Thomas C. Spelsberg, & Ralf Janknecht. (2008). Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors. Journal of Cellular Biochemistry. 105(3). 866–874. 49 indexed citations
4.
Bosc, Denis G. & Ralf Janknecht. (2002). Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81. Journal of Cellular Biochemistry. 86(1). 174–183. 39 indexed citations
5.
Bosc, Denis G., Basem S. Goueli, & Ralf Janknecht. (2001). HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene. 20(43). 6215–6224. 98 indexed citations
6.
Litchfield, David W., Denis G. Bosc, David A. Canton, et al.. (2001). Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners. PubMed. 227(1-2). 21–29. 33 indexed citations
7.
Litchfield, David W., Denis G. Bosc, David A. Canton, et al.. (2001). Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners. Molecular and Cellular Biochemistry. 227(1-2). 21–29. 42 indexed citations
8.
Bosc, Denis G., Kevin C. Graham, Ronald B. Saulnier, et al.. (2000). Identification and Characterization of CKIP-1, a Novel Pleckstrin Homology Domain-containing Protein That Interacts with Protein Kinase CK2. Journal of Biological Chemistry. 275(19). 14295–14306. 94 indexed citations
9.
Bosc, Denis G., Bernhard Lüscher, & David W. Litchfield. (1999). Expression and regulation of protein kinase CK2 during the cell cycle. Molecular and Cellular Biochemistry. 191(1-2). 213–222. 46 indexed citations
10.
Bosc, Denis G., Bernhard Lüscher, & David W. Litchfield. (1999). Expression and regulation of protein kinase CK2 during the cell cycle. PubMed. 191(1-2). 213–222. 48 indexed citations
11.
Shi, L, et al.. (1996). Granzyme B induces apoptosis and cyclin A-associated cyclin-dependent kinase activity in all stages of the cell cycle. The Journal of Immunology. 157(6). 2381–2385. 50 indexed citations
12.
Litchfield, David W., et al.. (1996). Analysis of interactions between the subunits of protein kinase CK2. Biochemistry and Cell Biology. 74(4). 541–547. 16 indexed citations
13.
Doble, Bradley W., Yijing Chen, Denis G. Bosc, David W. Litchfield, & Elissavet Kardami. (1996). Fibroblast Growth Factor-2 Decreases Metabolic Coupling and Stimulates Phosphorylation as Well as Masking of Connexin43 Epitopes in Cardiac Myocytes. Circulation Research. 79(4). 647–658. 86 indexed citations
14.
Litchfield, David W., et al.. (1995). The protein kinase from mitotic human cells that phosphorylates Ser-209 on the casein kinase II β-subunit is p34cdc2. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1269(1). 69–78. 24 indexed citations
15.
Bosc, Denis G., et al.. (1995). Phosphorylation of Casein Kinase II by p34cdc2. Journal of Biological Chemistry. 270(43). 25872–25878. 68 indexed citations
16.
Foufelle, Fabienne, Nathalie Lepetit, Denis G. Bosc, et al.. (1995). DNase I hypersensitivity sites and nuclear protein binding on the fatty acid synthase gene: identification of an element with properties similar to known glucose-responsive elements. Biochemical Journal. 308(2). 521–527. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026